Quick Takeaways
- CDNA - CareDx, Inc. has 23 insiders with reported activity on this page.
- Net insider value flow over the last year: -$3,392,629.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 23 Insiders of CareDx, Inc.
- Symbol
- CDNA on Nasdaq
- Location
- Brisbane, CA
What Changed
- Buy value: ; sell value: $3,392,628.
- Net share flow: -188,512.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$3,392,629.
Buys
$0
Shares: 0
Insiders: 0
Sells
$3,392,629
Shares: 188,512
Insiders: 6
Net
-$3,392,629
Shares: -188,512
Insiders: -6
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 34,077 | $0 | $717,313 | -$717,313 |
| 3-6 | 0 | 9,981 | $0 | $181,527 | -$181,527 |
| 6-9 | 0 | 2,688 | $0 | $34,381 | -$34,381 |
| 9-12 | 0 | 141,766 | $0 | $2,459,408 | -$2,459,408 |
CareDx, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| John Walter Hanna Jr. | President and CEO, Director | $14,107,505 | -$626,027 | -4.2% | Mixed | 01 Apr 2026 |
| Alexander L. Johnson | President of Patient and Testing Services | $9,284,746 | Filing P/S | 20 Aug 2024 | ||
| Abraham Ronai | Officer | $6,160,873 | Mixed | 20 Sep 2023 | ||
| Peter Maag | Director | $5,745,904 | -$607,047 | -9.6% | Mixed | 07 Jul 2025 |
| Reginald Seeto | President and Chief Executive Officer, Director | $5,721,218 | Mixed | 02 Oct 2023 | ||
| Abhishek Jain | Chief Financial Officer | $3,907,039 | Mixed | 01 Aug 2025 | ||
| Keith Kennedy | Cfo & Coo | $3,719,279 | Mixed | 01 Apr 2026 | ||
| Michael Goldberg | Director | $3,503,147 | Mixed | 02 Apr 2026 | ||
| Jessica Meng | Chief Commercial Officer | $3,191,345 | Mixed | 01 Apr 2026 | ||
| Fred E. Cohen | Director | $2,811,026 | Mixed | 13 Jun 2025 | ||
| Jeffrey Adam Novack | Secretary and General Counsel | $2,074,259 | -$346,708 | -14% | Median | 06 Apr 2026 |
| Sasha King | Chief Marketing Officer | $1,697,173 | Mixed | 09 Aug 2022 | ||
| Nathan Smith | Chief Financial Officer | $1,613,506 | Mixed | 02 Feb 2026 | ||
| William A. Hagstrom | Director | $1,158,857 | -$909,331 | -44% | Mixed | 11 Jun 2025 |
| George Bickerstaff | Director | $1,148,357 | Mixed | 11 Sep 2025 | ||
| Arthur A. Torres | Director | $949,139 | Mixed | 13 Jun 2025 | ||
| Christine Cournoyer | Director | $947,611 | -$700,951 | -43% | Mixed | 13 Jun 2025 |
| Hannah Valantine | Director | $747,288 | -$202,566 | -21% | Filing P/S | 18 Jun 2025 |
| Ralph Snyderman | Director | $694,633 | Mixed | 04 Oct 2022 | ||
| Richard Bryan Riggsbee | Director | $602,891 | Mixed | 13 Jun 2025 | ||
| Ankur Dhingra | Chief Financial Officer | $455,463 | Mixed | 25 Mar 2022 | ||
| Suresh Gunasekaran | Director | $399,166 | Mixed | 22 Oct 2025 | ||
| Grace Colon | Director | $283,074 | Mixed | 16 Jun 2023 |
Top shareholders of CareDx, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
8%
from 13D/G
|
4,650,409
|
$87,613,706 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
3,428,252
|
$64,588,269 | — | 31 Dec 2025 | |
| BAMCO INC /NY/ |
13F
13D/G
|
Company · Baron Capital Group, Inc. |
5.9%
from 13D/G
|
3,155,180
|
$59,443,591 | — | 31 Dec 2025 | |
| GAGNON SECURITIES LLC |
13D/G
13F
|
Neil Gagnon · Company |
5.9%
|
3,054,946
|
$58,471,666 | +$3,070,152 | 31 Dec 2025 | |
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
5.3%
|
2,737,752
|
$52,400,573 | $0 | 31 Dec 2025 | |
| ARK Investment Management LLC |
13D/G
13F
|
Company |
4.5%
|
2,409,099
|
$43,676,965 | -$10,506,299 | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
4.2%
|
2,191,000
|
$41,278,440 | — | 31 Dec 2025 | |
| BRAIDWELL LP |
13F
|
Company |
3.1%
|
1,585,220
|
$29,865,545 | — | 31 Dec 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
2.8%
|
1,446,616
|
$27,254,245 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
2.8%
|
1,446,616
|
$27,254,245 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.5%
|
1,309,980
|
$24,680,818 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,243,967
|
$23,440,229 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.1%
|
1,105,198
|
$20,821,930 | — | 31 Dec 2025 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
2.1%
|
1,081,342
|
$20,372,484 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2%
|
1,038,486
|
$19,565,076 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.8%
|
948,557
|
$17,870,814 | — | 31 Dec 2025 | |
| Ophir Asset Management Pty Ltd |
13F
|
Company |
1.8%
|
925,433
|
$17,435,158 | — | 31 Dec 2025 | |
| Boston Partners |
13F
|
Company |
1.7%
|
901,929
|
$16,994,213 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
811,186
|
$15,282,744 | — | 31 Dec 2025 | |
| Portolan Capital Management, LLC |
13F
|
Company |
1.5%
|
758,775
|
$14,295,321 | — | 31 Dec 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.5%
|
758,400
|
$14,288,256 | — | 31 Dec 2025 | |
| John Walter Hanna Jr. |
3/4/5
|
President and CEO, Director |
1.4%
|
748,806
|
$14,107,505 | -$626,027 | 01 Apr 2026 | |
| Zweig-DiMenna Associates LLC |
13F
|
Company |
1.3%
|
679,000
|
$12,792,360 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.3%
|
665,065
|
$12,529,825 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
642,762
|
$12,109,636 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.1%
|
581,211
|
$10,950,015 | — | 31 Dec 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
1.1%
|
546,722
|
$10,300,243 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
541,522
|
$10,202,285 | — | 31 Dec 2025 | |
| Gagnon Advisors, LLC |
13F
|
Company |
1%
|
532,892
|
$10,039,685 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
525,009
|
$9,891,170 | — | 31 Dec 2025 | |
| Blue Water Life Science Advisors, LP |
13F
|
Company |
0.98%
|
510,000
|
$9,608,400 | — | 31 Dec 2025 | |
| Alexander L. Johnson |
3/4/5
|
President of Patient and Testing Services |
—
mixed-class rows
|
334,552
mixed-class rows
|
$9,284,746 | — | 20 Aug 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.94%
|
487,050
|
$9,176,022 | — | 31 Dec 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.92%
|
478,220
|
$9,009,665 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.87%
|
449,886
|
$8,475,852 | — | 31 Dec 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.83%
|
431,070
|
$8,121,359 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.83%
|
430,229
|
$8,105,514 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.81%
|
420,225
|
$7,917,046 | — | 31 Dec 2025 | |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE |
13F
|
Company |
0.72%
|
375,000
|
$7,065,000 | — | 31 Dec 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.72%
|
371,409
|
$6,997,346 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.67%
|
345,308
|
$6,505,603 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.64%
|
333,898
|
$6,290,639 | — | 31 Dec 2025 | |
| Abraham Ronai |
3/4/5
|
Officer |
—
class O/S missing
|
515,986
|
$6,160,873 | — | 20 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
324,825
|
$6,119,703 | — | 31 Dec 2025 | |
| Peter Maag |
3/4/5
|
Director |
—
mixed-class rows
|
312,524
mixed-class rows
|
$5,745,904 | -$607,047 | 07 Jul 2025 | |
| Reginald Seeto |
3/4/5
|
President and Chief Executive Officer, Director |
—
class O/S missing
|
479,164
|
$5,721,218 | — | 02 Oct 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.59%
|
303,035
|
$5,709,180 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.56%
|
287,561
|
$5,417,759 | — | 31 Dec 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.53%
|
276,154
|
$5,202,741 | — | 31 Dec 2025 | |
| Prosight Management, LP |
13F
|
Company |
0.48%
|
250,000
|
$4,710,000 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for CareDx, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -1.56% | -1,892 | 119,485 | 06 Apr 2026 | Direct | ||
| Michael Goldberg | CDNA | Common Stock | Award | 1.08% | 1,981 | 185,942 | 02 Apr 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Tax liability | -4.47% | -35,037 | 748,806 | 01 Apr 2026 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Tax liability | -5.61% | -11,725 | 197,414 | 01 Apr 2026 | Direct | ||
| Jessica Meng | CDNA | Common Stock | Tax liability | -4.18% | -7,386 | 169,392 | 01 Apr 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -3.18% | -3,987 | 121,377 | 01 Apr 2026 | Direct | ||
| Michael Goldberg | CDNA | Common Stock | Options Exercise | 16.8% | 26,500 | 183,961 | 31 Mar 2026 | Direct | ||
| Michael Goldberg | CDNA | Stock Option | Options Exercise | -100% | -11,500 | 0 | 31 Mar 2026 | Direct | ||
| Michael Goldberg | CDNA | Stock Option (right to buy) | Options Exercise | -100% | -15,000 | 0 | 31 Mar 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -3.42% | $91,286 | $20.56 | -4,441 | 125,364 | 03 Feb 2026 | Direct |
| Nathan Smith | CDNA | Common Stock | Tax liability | -4.66% | -3,859 | 79,016 | 02 Feb 2026 | Direct | ||
| Nathan Smith | CDNA | Common Stock | Award | 97.3% | 40,875 | 82,875 | 02 Feb 2026 | Direct | ||
| Jessica Meng | CDNA | Common Stock | Tax liability | -2.44% | -4,430 | 176,778 | 02 Feb 2026 | Direct | ||
| Jessica Meng | CDNA | Common Stock | Award | 65.3% | 71,579 | 181,208 | 02 Feb 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -4.04% | -5,462 | 129,805 | 02 Feb 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Award | 38.1% | 37,342 | 135,267 | 02 Feb 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Tax liability | -1.72% | -13,694 | 783,843 | 02 Feb 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Award | 33.5% | 200,132 | 797,537 | 02 Feb 2026 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Tax liability | -2.17% | -4,644 | 209,139 | 02 Feb 2026 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Award | 53.5% | 74,474 | 213,783 | 02 Feb 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -3.13% | $408,023 | $21.16 | -19,280 | 597,405 | 22 Jan 2026 | Direct |
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -0.03% | $4,200 | $21.00 | -200 | 616,685 | 21 Jan 2026 | Direct |
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -1.62% | $213,804 | $21.05 | -10,156 | 616,885 | 15 Jan 2026 | Direct |
| Michael Goldberg | CDNA | Common Stock | Award | 0.96% | 1,492 | 157,461 | 06 Jan 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -6.93% | $139,804 | $19.17 | -7,293 | 97,925 | 04 Dec 2025 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -2.49% | $41,723 | $15.52 | -2,688 | 105,218 | 07 Nov 2025 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -1.96% | -2,152 | 107,906 | 06 Nov 2025 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -2.54% | -2,872 | 110,058 | 01 Nov 2025 | Direct | ||
| Suresh Gunasekaran | CDNA | Common Stock | Award | 27,453 | 27,453 | 22 Oct 2025 | Direct | |||
| Michael Goldberg | CDNA | Common Stock | Award | 1.14% | 1,753 | 155,969 | 06 Oct 2025 | Direct | ||
| Jessica Meng | CDNA | Common Stock | Tax liability | -4.11% | -4,703 | 109,629 | 12 Sep 2025 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Tax liability | -5.42% | -7,987 | 139,309 | 12 Sep 2025 | Direct | ||
| George Bickerstaff | CDNA | Common Stock | Options Exercise | 25.3% | 29,136 | 144,266 | 11 Sep 2025 | Direct | ||
| George Bickerstaff | CDNA | Stock Option (right to buy) | Options Exercise | -100% | -29,136 | 0 | 11 Sep 2025 | Direct | ||
| Nathan Smith | CDNA | Common Stock | Award | 42,000 | 42,000 | 07 Aug 2025 | Direct | |||
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -2.32% | $34,381 | $12.79 | -2,688 | 112,930 | 05 Aug 2025 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -2.42% | -2,873 | 115,618 | 01 Aug 2025 | Direct | ||
| Abhishek Jain | CDNA | Common Stock | Tax liability | -2.35% | -7,687 | 319,725 | 01 Aug 2025 | Direct | ||
| Michael Goldberg | CDNA | Common Stock | Award | 0.8% | 1,218 | 154,216 | 08 Jul 2025 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -0.23% | -276 | 118,491 | 07 Jul 2025 | Direct | ||
| Peter Maag | CDNA | Common Stock | Sale | -3.14% | $185,831 | $18.58 | -10,000 | 308,846 | 07 Jul 2025 | Direct |
| Hannah Valantine | CDNA | Common Stock | Sale | -21.3% | $202,566 | $19.16 | -10,570 | 38,994 | 18 Jun 2025 | Direct |
| Peter Maag | CDNA | Common Stock | Sale | -3.04% | $192,420 | $19.24 | -10,000 | 318,846 | 17 Jun 2025 | Direct |
| Michael Goldberg | CDNA | Common Stock | Award | 8.59% | 12,103 | 152,998 | 13 Jun 2025 | Direct | ||
| Fred E. Cohen | CDNA | Common Stock | Award | 8.45% | 12,103 | 155,265 | 13 Jun 2025 | Direct | ||
| Peter Maag | CDNA | Common Stock | Award | 3.82% | 12,103 | 328,846 | 13 Jun 2025 | Direct | ||
| Richard Bryan Riggsbee | CDNA | Common Stock | Award | 69.5% | 12,103 | 29,517 | 13 Jun 2025 | Direct | ||
| George W. Bickerstaff III | CDNA | Common Stock | Award | 11.8% | 12,103 | 115,130 | 13 Jun 2025 | Direct | ||
| Hannah Valantine | CDNA | Common Stock | Award | 32.3% | 12,103 | 49,564 | 13 Jun 2025 | Direct | ||
| Christine Cournoyer | CDNA | Common Stock | Award | 32.7% | 12,103 | 49,148 | 13 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.